Standard BioTools Inc.
LAB
$1.01
$0.000.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 86.26M | 85.33M | 86.31M | 88.85M | 89.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 86.26M | 85.33M | 86.31M | 88.85M | 89.58M |
| Cost of Revenue | 45.41M | 47.89M | 48.90M | 48.79M | 49.77M |
| Gross Profit | 40.85M | 37.44M | 37.42M | 40.06M | 39.81M |
| SG&A Expenses | 98.64M | 109.86M | 111.84M | 109.71M | 106.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 164.76M | 178.64M | 180.70M | 179.04M | 177.80M |
| Operating Income | -78.51M | -93.31M | -94.38M | -90.19M | -88.23M |
| Income Before Tax | -87.83M | -96.70M | -101.57M | -90.47M | -97.60M |
| Income Tax Expenses | -37.75M | -37.88M | -1.67M | -338.00K | 310.00K |
| Earnings from Continuing Operations | -50.08 | -58.83 | -99.90 | -90.14 | -97.91 |
| Earnings from Discontinued Operations | 128.29M | -16.07M | -28.35M | -30.37M | -34.86M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 78.21M | -74.90M | -128.25M | -120.50M | -132.76M |
| EBIT | -78.51M | -93.31M | -94.38M | -90.19M | -88.23M |
| EBITDA | -66.22M | -80.34M | -74.21M | -65.25M | -62.87M |
| EPS Basic | 0.20 | -0.20 | -0.34 | -0.32 | -0.36 |
| Normalized Basic EPS | -0.10 | -0.13 | -0.14 | -0.13 | -0.13 |
| EPS Diluted | 0.20 | -0.20 | -0.34 | -0.32 | -0.36 |
| Normalized Diluted EPS | -0.10 | -0.13 | -0.14 | -0.13 | -0.13 |
| Average Basic Shares Outstanding | 1.54B | 1.53B | 1.52B | 1.50B | 1.50B |
| Average Diluted Shares Outstanding | 1.54B | 1.53B | 1.52B | 1.50B | 1.50B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |